Why the study?
Does age influence the utilization and mortality benefit of coronary reperfusion therapy in patients with ST-segment elevation acute myocardial infarction?
Population
930 patients with ST-segment elevation acute myocardial infarction prospectively enrolled in the Florence…
Comparison
Coronary reperfusion therapy, primarily… vs No coronary reperfusion therapy / comparison…
Design
Cohort
Follow-up
1 year
Authors
Loading...
CRT underuse in older STE-AMI patients may reflect appropriate caution; observational data leave open mortality benefit in those ≥85 years.
Does age influence the utilization and mortality benefit of coronary reperfusion therapy in patients with ST-segment elevation acute myocardial infarction?
Older patients with STE-AMI are significantly less likely to receive coronary reperfusion therapy despite potential mortality benefits, highlighting a gap in geriatric cardiology care.
Barchielli et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: